01801.HK
Innovent Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 102.40
−0.19%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- HKD 1.33
- Revenue estimate
- HKD 11.8B
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- HKD 0.81
- EPS estimate
- HKD 0.54
- Revenue actual
- HKD 9.9B
- Revenue estimate
- HKD 10.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +49.1%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027